{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:37:43Z","timestamp":1787017063877,"version":"build-2736575974"},"reference-count":23,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1136\/bjophthalmol-2013-304501","type":"journal-article","created":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T00:39:40Z","timestamp":1393375180000},"page":"775-779","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":39,"title":["Trans-scleral local resection of toxic choroidal melanoma after proton beam radiotherapy"],"prefix":"10.1136","volume":"98","author":[{"given":"Lazaros","family":"Konstantinidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Groenewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E","family":"Coupland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertil","family":"Damato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2014,2,25]]},"reference":[{"key":"key-10.1136\/bjophthalmol-2013-304501-1","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/eye.2012.126","article-title":"Progress in the management of patients with uveal melanoma. The 2012 Ashton Lecture","volume":"26","author":"Damato","year":"2012","journal-title":". Eye (Lond)"},{"key":"key-10.1136\/bjophthalmol-2013-304501-2","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0161-6420(89)32738-2","article-title":"The risk of enucleation after proton beam irradiation of uveal melanoma","volume":"96","author":"Egan","year":"1989","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2013-304501-3","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0360-3016(02)04200-1","article-title":"Eye retention after proton beam radiotherapy for uveal melanoma","volume":"55","author":"Egger","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key-10.1136\/bjophthalmol-2013-304501-4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0360-3016(01)01560-7","article-title":"Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma","volume":"51","author":"Egger","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key-10.1136\/bjophthalmol-2013-304501-5","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0161-6420(92)31900-1","article-title":"Intraocular recurrence of uveal melanoma after proton beam irradiation","volume":"99","author":"Gragoudas","year":"1992","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2013-304501-6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/0002-9394(85)90357-5","article-title":"Comparison of survival rates for patients with uveal melanoma after treatment with proton beam irradiation or enucleation","volume":"99","author":"Seddon","year":"1985","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2013-304501-7","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijrobp.2013.05.051","article-title":"Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters","volume":"87","author":"Mishra","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key-10.1136\/bjophthalmol-2013-304501-8","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0360-3016(97)00557-9","article-title":"Anterior segment sparing to reduce charged particle radiotherapy complications in uveal melanoma","volume":"39","author":"Daftari","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key-10.1136\/bjophthalmol-2013-304501-9","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1136\/bjophthalmol-2012-302659","article-title":"Whole anterior segment proton beam radiotherapy for diffuse iris melanoma","volume":"97","author":"Konstantinidis","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2013-304501-10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijrobp.2005.01.050","article-title":"Proton beam radiotherapy of iris melanoma","volume":"63","author":"Damato","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key-10.1136\/bjophthalmol-2013-304501-11","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0161-6420(02)01273-3","article-title":"Iodine 125 plaque brachytherapy versus transscleral tumor resection in the treatment of large uveal melanomas","volume":"109","author":"Bechrakis","year":"2002","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2013-304501-12","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/IAE.0b013e31827f65c8","article-title":"Choroidal melanoma: does endoresection prevent neovascular glaucoma in patient treated with proton beam irradiation","volume":"33","author":"Cassoux","year":"2013","journal-title":"Retina"},{"key":"key-10.1136\/bjophthalmol-2013-304501-13","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.ijrobp.2005.01.016","article-title":"Proton beam radiotherapy of choroidal melanoma: the Liverpool-Clatterbridge experience","volume":"62","author":"Damato","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key-10.1136\/bjophthalmol-2013-304501-14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000328261","article-title":"Local resection of uveal melanoma","volume":"49","author":"Damato","year":"2012","journal-title":"Dev Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2013-304501-15","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.ophtha.2007.06.012","article-title":"Cytogenetics of uveal melanoma: a 7-year clinical experience","volume":"114","author":"Damato","year":"2007","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2013-304501-16","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-10-2076","article-title":"Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification","volume":"16","author":"Damato","year":"2010","journal-title":"Clin Cancer Res"},{"key":"key-10.1136\/bjophthalmol-2013-304501-17","article-title":"Secondary local resection for \u201ctoxic tumor\u201d after radiotherapy","volume-title":"Retina","author":"Damato","edition":"5"},{"key":"key-10.1136\/bjophthalmol-2013-304501-18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ohc.2004.08.010","article-title":"Uveal melanoma: resection techniques","volume":"18","author":"Damato","year":"2005","journal-title":"Ophthalmol Clin North Am"},{"key":"key-10.1136\/bjophthalmol-2013-304501-19","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/eye.2013.115","article-title":"Post-brachytherapy tumor endoresection for treatment of toxic maculopathy in choroidal melanoma","volume":"27","author":"McCannel","year":"2013","journal-title":"Eye (Lond)"},{"key":"key-10.1136\/bjophthalmol-2013-304501-20","doi-asserted-by":"crossref","first-page":"796","DOI":"10.5301\/EJO.2011.6477","article-title":"Systemic bevacizumab (Avastin) for exudative retinal detachment secondary to choroidal melanoma","volume":"21","author":"Newman","year":"2011","journal-title":"Eur J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2013-304501-21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ajo.2012.06.026","article-title":"Intravitreal triamcinolone vs intravitreal bevacizumab in the treatment of exudative retinal detachment secondary to posterior uveal melanoma","volume":"155","author":"Parrozzani","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2013-304501-22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3129\/i08-171","article-title":"Intracameral bevacizumab in the treatment of neovascular glaucoma and exudative retinal detachment after brachytherapy in choroidal melanoma","volume":"44","author":"V\u00e1squez","year":"2009","journal-title":"Can J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2013-304501-23","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1442-9071.2007.01632.x","article-title":"Rapid improvement of radiation-induced neovascular glaucoma and exudative retinal detachment after a single intravitreal ranibizumab injection","volume":"35","author":"Dunavoelgyi","year":"2007","journal-title":"Clin Experiment Ophthalmol"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2013-304501","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T04:46:38Z","timestamp":1601095598000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2013-304501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,25]]},"references-count":23,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,5,17]]},"published-print":{"date-parts":[[2014,6]]}},"alternative-id":["10.1136\/bjophthalmol-2013-304501"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2013-304501","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,25]]}}}